South San Francisco, CA, June 20, 2018 – Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in...
Art will provide featured remarks to the Harvard Business School on personalized medicine and venture capital on Thursday, March 29 in Boston, MA.
News | 03. 19. 2012
Art will provide featured remarks to the Harvard Business School on personalized medicine and venture capital on Thursday, March 29 in Boston, MA.
